Francesca Incampo

Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin‐activatable fibrinolysis inhibitor

Concetta T. Ammollo, Fabrizio Semeraro, Francesca Incampo et al. · Journal of Thrombosis and Haemostasis · 2010 · 107 citations · Full text

Thrombosis, Mechanisms Dependent, Thrombin‐activatable Fibrinolysis Inhibitor +11

Antithrombotic activity of 12 table grape varieties. Relationship with polyphenolic profile

Cosimo Carrieri, Rosa Anna Milella, Francesca Incampo et al. · Food Chemistry · 2012 · 40 citations

Food Chemistry, Food Bioactive Compound, Wine Perception +8

Randomised trial of chronic supplementation with a nutraceutical mixture in subjects with non-alcoholic fatty liver disease

Chiara Cerletti, Mario Colucci, Marianna Storto et al. · British Journal Of Nutrition · 2019 · 35 citations · Full text

Reduced fibrinolytic resistance in patients with factor XI deficiency. Evidence of a thrombin‐independent impairment of the thrombin‐activatable fibrinolysis inhibitor pathway

Mario Colucci, Francesca Incampo, Antonino Cannavò et al. · Journal of Thrombosis and Haemostasis · 2016 · 33 citations

Thrombosis, Cardiovascular Disease, Hematology +10

Dabigatran but not rivaroxaban or apixaban treatment decreases fibrinolytic resistance in patients with atrial fibrillation

Fabrizio Semeraro, Francesca Incampo, Concetta T. Ammollo et al. · Thrombosis Research · 2015 · 29 citations · Full text

Thrombosis, Cardiovascular Disease, Pharmacology +12